Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (338)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
30
2025
187
13.140
 Why?
Anticonvulsants
20
2025
134
8.920
 Why?
Seizures
24
2025
209
6.170
 Why?
Tuberous Sclerosis
8
2025
39
4.310
 Why?
Spasms, Infantile
11
2025
30
4.190
 Why?
Cannabidiol
8
2025
43
3.990
 Why?
Status Epilepticus
6
2021
37
3.290
 Why?
Epilepsies, Myoclonic
5
2024
14
3.070
 Why?
Mutation
16
2023
1342
3.010
 Why?
Deep Brain Stimulation
4
2025
43
2.800
 Why?
Humans
118
2025
52513
2.660
 Why?
Electroencephalography
18
2024
303
2.490
 Why?
Child
43
2025
7218
2.200
 Why?
Intellectual Disability
5
2023
127
2.170
 Why?
Brain
10
2024
1319
2.100
 Why?
Hemiplegia
3
2021
11
1.990
 Why?
Developmental Disabilities
5
2019
121
1.670
 Why?
Epilepsy, Absence
3
2019
11
1.620
 Why?
Magnetic Resonance Imaging
16
2025
1535
1.590
 Why?
Infant
24
2025
3713
1.560
 Why?
Genetic Therapy
2
2025
122
1.480
 Why?
Algorithms
2
2025
667
1.390
 Why?
Tumor Suppressor Proteins
3
2023
128
1.380
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.380
 Why?
Nervous System Malformations
3
2020
16
1.370
 Why?
Folate Receptor 1
2
2022
27
1.340
 Why?
Child, Preschool
22
2025
4056
1.300
 Why?
Epilepsies, Partial
2
2022
14
1.260
 Why?
Infant, Newborn, Diseases
2
2020
57
1.260
 Why?
Ketamine
2
2020
59
1.250
 Why?
Vagus Nerve Stimulation
2
2025
14
1.150
 Why?
Neurocutaneous Syndromes
2
2019
6
1.130
 Why?
Cadherins
2
2019
63
1.110
 Why?
Cerebral Arteries
2
2019
30
1.040
 Why?
Epilepsy, Generalized
2
2023
9
1.020
 Why?
Vigabatrin
3
2024
3
1.010
 Why?
Sirolimus
2
2017
72
1.000
 Why?
Angiofibroma
2
2015
5
0.970
 Why?
Male
38
2025
26816
0.960
 Why?
Facial Neoplasms
2
2015
22
0.960
 Why?
Nerve Tissue Proteins
2
2018
192
0.940
 Why?
Treatment Outcome
13
2025
5480
0.940
 Why?
Female
34
2025
28219
0.940
 Why?
Valproic Acid
2
2022
35
0.930
 Why?
Neurosurgical Procedures
2
2025
134
0.930
 Why?
Stroke
3
2019
515
0.890
 Why?
Fenfluramine
2
2024
7
0.890
 Why?
Randomized Controlled Trials as Topic
2
2024
600
0.880
 Why?
Dioxolanes
2
2024
15
0.880
 Why?
Thalamus
1
2024
35
0.880
 Why?
Pregnanolone
2
2023
6
0.850
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.800
 Why?
Quality Improvement
2
2022
224
0.770
 Why?
Aphasia
1
2022
33
0.760
 Why?
Nervous System Diseases
2
2021
94
0.740
 Why?
Chromosome Deletion
3
2019
141
0.740
 Why?
Abnormalities, Multiple
3
2023
168
0.730
 Why?
Emergencies
1
2021
81
0.700
 Why?
Pharmaceutical Preparations
1
2021
75
0.700
 Why?
Angelman Syndrome
1
2020
1
0.690
 Why?
Adolescent
16
2025
6725
0.690
 Why?
Transition to Adult Care
1
2020
18
0.680
 Why?
Bone Diseases, Developmental
2
2023
17
0.670
 Why?
Tooth Abnormalities
2
2023
13
0.670
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.660
 Why?
Oligonucleotides, Antisense
1
2020
29
0.660
 Why?
Phenobarbital
1
2020
17
0.650
 Why?
Flunarizine
1
2019
1
0.650
 Why?
Behavioral Symptoms
1
2019
4
0.650
 Why?
Immunologic Factors
1
2021
117
0.650
 Why?
Excitatory Amino Acid Antagonists
1
2020
46
0.650
 Why?
Ocular Physiological Phenomena
1
2019
3
0.640
 Why?
Tetrasomy
1
2019
2
0.630
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.630
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.630
 Why?
Sneddon Syndrome
1
2019
3
0.630
 Why?
Livedo Reticularis
1
2019
5
0.630
 Why?
Oral Ulcer
1
2019
3
0.630
 Why?
Calcium Channel Blockers
1
2019
60
0.620
 Why?
Behcet Syndrome
1
2019
7
0.620
 Why?
Transposases
1
2019
10
0.620
 Why?
Andersen Syndrome
1
2019
1
0.620
 Why?
Spinal Cord Diseases
1
2019
39
0.610
 Why?
Hydrocephalus
1
2019
43
0.610
 Why?
Receptors, GABA-B
1
2019
12
0.610
 Why?
Vitiligo
1
2019
8
0.610
 Why?
Leukoencephalopathies
1
2019
14
0.610
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.610
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.600
 Why?
Edema
1
2019
65
0.600
 Why?
Migraine Disorders
2
2020
47
0.600
 Why?
Cerebral Infarction
1
2018
31
0.600
 Why?
Electron Transport Complex IV
1
2018
24
0.600
 Why?
Muscle Weakness
1
2019
45
0.590
 Why?
Nephrotic Syndrome
2
2017
34
0.590
 Why?
Cannabinoid Receptor Agonists
1
2019
50
0.590
 Why?
Physicians
1
2022
241
0.590
 Why?
Optic Atrophy
1
2018
16
0.590
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.590
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.590
 Why?
Photic Stimulation
1
2018
56
0.590
 Why?
Shab Potassium Channels
1
2018
2
0.590
 Why?
Alopecia
1
2019
38
0.590
 Why?
Brain Edema
1
2018
36
0.580
 Why?
Parents
1
2021
332
0.570
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.570
 Why?
Myoclonus
1
2018
9
0.570
 Why?
Artifacts
1
2018
55
0.570
 Why?
Thrombocytopenia
1
2019
92
0.570
 Why?
Autoimmune Diseases
1
2019
87
0.570
 Why?
Biomedical Research
1
2021
258
0.560
 Why?
Mitochondrial Diseases
1
2018
45
0.560
 Why?
Neurodegenerative Diseases
1
2018
81
0.550
 Why?
Practice Guidelines as Topic
1
2020
496
0.550
 Why?
Hearing Loss, Sensorineural
1
2018
79
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
509
0.530
 Why?
Osteochondrodysplasias
1
2017
14
0.530
 Why?
Immunologic Deficiency Syndromes
1
2017
18
0.530
 Why?
Models, Biological
1
2020
740
0.530
 Why?
Arteriosclerosis
1
2017
50
0.530
 Why?
Carotid Artery Diseases
1
2017
31
0.530
 Why?
Infant, Newborn
6
2024
2884
0.530
 Why?
Phenotype
2
2021
800
0.520
 Why?
Drug Discovery
1
2017
93
0.520
 Why?
Child Development
1
2018
201
0.510
 Why?
Prenatal Exposure Delayed Effects
1
2018
194
0.510
 Why?
Cafe-au-Lait Spots
1
2016
2
0.510
 Why?
Skin
1
2019
418
0.500
 Why?
Williams Syndrome
1
2016
25
0.500
 Why?
Erythema Infectiosum
1
2015
3
0.500
 Why?
Corpus Callosum
2
2023
26
0.490
 Why?
Migraine with Aura
1
2015
5
0.490
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.490
 Why?
Pulmonary Embolism
1
2017
84
0.490
 Why?
Sinus Pericranii
1
2015
1
0.490
 Why?
Syndrome
6
2024
252
0.490
 Why?
Parvovirus B19, Human
1
2015
17
0.490
 Why?
Toes
1
2015
15
0.490
 Why?
Electrodiagnosis
1
2015
13
0.490
 Why?
SOS1 Protein
1
2015
2
0.490
 Why?
Crying
1
2015
4
0.490
 Why?
Moyamoya Disease
1
2015
7
0.480
 Why?
Hyperventilation
1
2015
8
0.480
 Why?
Iatrogenic Disease
1
2015
26
0.480
 Why?
Tuberculoma
1
2015
1
0.480
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.480
 Why?
Noonan Syndrome
1
2015
12
0.480
 Why?
Neurologic Examination
1
2015
73
0.480
 Why?
Encephalitis
1
2016
39
0.480
 Why?
Communication
3
2022
257
0.470
 Why?
Ocular Motility Disorders
1
2015
17
0.470
 Why?
Mutism
1
2015
3
0.470
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.470
 Why?
Repressor Proteins
2
2023
153
0.470
 Why?
TOR Serine-Threonine Kinases
1
2015
82
0.470
 Why?
Diagnosis, Differential
7
2020
1045
0.460
 Why?
Trisomy
1
2014
35
0.460
 Why?
Neurology
1
2015
33
0.450
 Why?
Influenza, Human
1
2015
85
0.450
 Why?
KCNQ2 Potassium Channel
1
2014
8
0.450
 Why?
Energy Drinks
1
2014
6
0.450
 Why?
Vasoconstriction
1
2014
56
0.440
 Why?
Benzodiazepines
1
2014
72
0.440
 Why?
Osteomyelitis
1
2015
125
0.430
 Why?
Membrane Proteins
1
2016
336
0.430
 Why?
Sleep
1
2014
186
0.410
 Why?
Enzyme Inhibitors
1
2015
371
0.410
 Why?
Quality of Life
4
2025
881
0.390
 Why?
Magnetic Resonance Angiography
3
2019
67
0.390
 Why?
Immunosuppressive Agents
3
2019
250
0.380
 Why?
Consensus
2
2025
190
0.370
 Why?
Pediatrics
1
2015
294
0.370
 Why?
Retrospective Studies
8
2025
6661
0.360
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
78
0.350
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
133
0.330
 Why?
Clinical Trials as Topic
2
2024
472
0.330
 Why?
Caregivers
2
2021
238
0.310
 Why?
Recurrence
3
2019
681
0.300
 Why?
Echinocandins
1
2008
64
0.290
 Why?
Mycoses
1
2008
152
0.270
 Why?
Gastroesophageal Reflux
2
2019
48
0.270
 Why?
Antifungal Agents
1
2008
346
0.250
 Why?
Administration, Topical
2
2015
60
0.240
 Why?
Adult
6
2025
14148
0.240
 Why?
Seizures, Febrile
1
2024
2
0.230
 Why?
Meta-Analysis as Topic
1
2024
40
0.230
 Why?
Magnetoencephalography
1
2025
88
0.230
 Why?
Memory, Short-Term
1
2025
74
0.230
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
 Why?
Psychosurgery
1
2023
5
0.220
 Why?
Databases, Factual
2
2024
715
0.210
 Why?
Laser Therapy
1
2023
76
0.200
 Why?
Speech Disorders
1
2022
16
0.200
 Why?
Ethosuximide
1
2022
5
0.200
 Why?
Clonazepam
1
2022
6
0.200
 Why?
Electrodes, Implanted
1
2022
32
0.190
 Why?
Cluster Analysis
1
2023
233
0.190
 Why?
Stereotaxic Techniques
1
2022
40
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
25
0.190
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Palliative Care
1
2024
215
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.180
 Why?
Freedom
1
2021
3
0.180
 Why?
Folic Acid
1
2022
136
0.180
 Why?
Diazepam
1
2021
18
0.180
 Why?
Drug Interactions
1
2022
203
0.180
 Why?
Fibroma
1
2021
40
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
30
0.180
 Why?
Personal Satisfaction
1
2021
75
0.170
 Why?
Soft Tissue Neoplasms
1
2021
55
0.170
 Why?
Risk Factors
2
2020
3951
0.170
 Why?
Dihydroergotamine
1
2020
5
0.170
 Why?
Brain Diseases
1
2021
77
0.170
 Why?
Perception
1
2021
120
0.170
 Why?
Transcription Factors
2
2023
566
0.170
 Why?
Mental Disorders
1
2025
428
0.170
 Why?
Facies
2
2023
36
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
24
0.160
 Why?
Clinical Protocols
1
2020
108
0.160
 Why?
Treatment Failure
1
2020
122
0.160
 Why?
Anesthetics
1
2020
36
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Learning
1
2021
159
0.160
 Why?
Muscle Hypotonia
1
2019
23
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
30
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Qualitative Research
1
2021
360
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
29
0.160
 Why?
Patient-Centered Care
1
2021
140
0.160
 Why?
Ubiquitin-Protein Ligases
1
2020
137
0.150
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.150
 Why?
Disease Management
1
2020
186
0.150
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
 Why?
Ventricular Premature Complexes
1
2019
6
0.150
 Why?
Microcephaly
1
2019
41
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Referral and Consultation
1
2021
292
0.150
 Why?
Syncope
1
2019
31
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
17
0.150
 Why?
Facial Paralysis
1
2018
25
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.150
 Why?
Health Personnel
1
2021
252
0.150
 Why?
Deglutition Disorders
1
2019
79
0.150
 Why?
Fatal Outcome
1
2019
195
0.140
 Why?
Acute Disease
1
2019
387
0.140
 Why?
Video Recording
1
2018
79
0.140
 Why?
Frameshift Mutation
1
2018
18
0.140
 Why?
Fibrinolytic Agents
1
2019
131
0.140
 Why?
Combined Modality Therapy
1
2020
636
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
80
0.140
 Why?
India
1
2017
64
0.140
 Why?
Cerebellum
1
2018
125
0.140
 Why?
History, 21st Century
1
2017
59
0.140
 Why?
History, 20th Century
1
2017
96
0.140
 Why?
Platelet Aggregation Inhibitors
1
2019
213
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.130
 Why?
Methotrexate
1
2017
77
0.130
 Why?
Pandemics
1
2021
586
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.130
 Why?
Animals
3
2022
13464
0.130
 Why?
Anti-Infective Agents
1
2017
106
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
24
0.120
 Why?
Hormones
1
2016
59
0.120
 Why?
Influenza B virus
1
2015
6
0.120
 Why?
Delayed Diagnosis
1
2016
30
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
 Why?
Arkansas
1
2021
2029
0.120
 Why?
North America
1
2015
77
0.120
 Why?
Cerebral Angiography
1
2015
90
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
79
0.120
 Why?
Complementary Therapies
1
2015
23
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.110
 Why?
Brain Waves
1
2014
19
0.110
 Why?
Drug Resistance
1
2015
68
0.110
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
460
0.110
 Why?
Headache
1
2014
76
0.110
 Why?
Mutation, Missense
1
2014
108
0.110
 Why?
Glutamine
1
2015
176
0.110
 Why?
Vomiting
1
2014
73
0.110
 Why?
Arginine
1
2015
182
0.100
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.100
 Why?
Analgesics
1
2014
104
0.100
 Why?
Diagnostic Errors
1
2013
69
0.100
 Why?
Evidence-Based Medicine
1
2013
269
0.090
 Why?
Inflammation
1
2016
644
0.090
 Why?
Pregnancy
1
2018
2672
0.090
 Why?
Signal Transduction
1
2017
1707
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Antineoplastic Agents
1
2017
1219
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
44
0.070
 Why?
Lipopeptides
1
2008
62
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
152
0.070
 Why?
Candidiasis
1
2008
113
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
86
0.070
 Why?
Kidney Diseases
1
2009
231
0.060
 Why?
Prospective Studies
2
2023
2451
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
48
0.060
 Why?
Observer Variation
1
2024
132
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
485
0.050
 Why?
Probability
1
2023
173
0.050
 Why?
Young Adult
2
2025
4326
0.050
 Why?
Neuroimaging
1
2023
94
0.050
 Why?
Pilot Projects
1
2025
719
0.050
 Why?
Potassium Channels
1
2021
32
0.050
 Why?
Reproducibility of Results
1
2024
1216
0.040
 Why?
Registries
1
2024
629
0.040
 Why?
Administration, Intravenous
1
2020
73
0.040
 Why?
Sleep Stages
1
2020
40
0.040
 Why?
Age of Onset
1
2020
110
0.040
 Why?
Cognition
1
2022
329
0.040
 Why?
Follow-Up Studies
1
2025
2290
0.040
 Why?
Immunohistochemistry
1
2021
981
0.040
 Why?
Aged
1
2025
10181
0.020
 Why?
Software
1
2013
280
0.020
 Why?
Internet
1
2013
261
0.020
 Why?
Middle Aged
1
2025
13081
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
107
0.020
 Why?
Colonoscopy
1
2009
107
0.020
 Why?
Prognosis
1
2009
2115
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (338) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department